 | LGD-2226 is an investigational selective androgen receptor modulator (SARM), which is being developed for treatment of muscle wasting and osteoporosis... 5 KB (460 words) - 01:12, 12 November 2022 |
 | 2013. LGD-4033 has sometimes been confused with other structurally related Ligand Pharmaceuticals SARMs including LGD-2226, LGD-2941, and LGD-3303, but... 55 KB (5,985 words) - 02:30, 19 April 2024 |
 | LGD-2941 is a drug which acts as a selective androgen receptor modulator (SARM). It is no longer being developed. Long YO, Higuchi RI, Caferro TR, Lau... 4 KB (96 words) - 13:41, 17 January 2024 |
 | assessed in this area, another structurally unrelated quinolinone SARM, LGD-2226, has shown prosexual effects in male rats comparable to those of the synthetic... 116 KB (12,879 words) - 02:46, 2 May 2024 |
| since then; the most commonly detected SARMs are enobosarm (ostarine) and LGD-4033 (ligandrol). Athletes competing in the NFL, NBA, UFC, NCAA, and the... 74 KB (6,753 words) - 23:47, 22 April 2024 |
 | LGD-3303 is a drug which acts as a selective androgen receptor modulator (SARM), with good oral bioavailability. It is a selective agonist for the androgen... 3 KB (203 words) - 20:12, 19 June 2022 |
 | GLPG-0492 GSK2881078 GSK-4336A GSK-8698 LG121071 (LGD-121071) LGD-2226 LGD-2941 (LGD-122941) LGD-3303 LGD-4033 LY305 JNJ-26146900 JNJ-28330835 JNJ-37654032... 29 KB (3,165 words) - 22:29, 23 March 2024 |
 | GLPG-0492 GSK2881078 GSK-4336A GSK-8698 LG121071 (LGD-121071) LGD-2226 LGD-2941 (LGD-122941) LGD-3303 LGD-4033 LY305 JNJ-26146900 JNJ-28330835 JNJ-37654032... 76 KB (7,454 words) - 03:11, 8 May 2024 |
 | other most commonly used SARMs include enobosarm (ostarine; GTx-024, S-22), LGD-4033 (VK5211; "ligandrol"), and andarine (GTx-007; S-4). Social media has... 27 KB (2,530 words) - 11:05, 5 March 2024 |
 | GLPG-0492 GSK2881078 GSK-4336A GSK-8698 LG121071 (LGD-121071) LGD-2226 LGD-2941 (LGD-122941) LGD-3303 LGD-4033 LY305 JNJ-26146900 JNJ-28330835 JNJ-37654032... 35 KB (3,320 words) - 13:25, 25 April 2024 |